Lyra Therapeutics Inc (LYRA) is a biotechnology company listed on US.
Latest reported LYRA revenue for 2024-12-31 was $1.5M. Net income was -$93.4M. Revenue was down 1.5% from 2023-12-31 to 2024-12-31. LYRA currently screens at market cap $14.4M.
Use this LYRA page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the LYRA quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the LYRA SEC filings page. Lician reads the product cache first so this HTML stays unique to Lyra Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full LYRA income, balance, and cash tables.